Immunotherapy in asthma: an updated systematic review

Allergen-specific immunotherapy (hyposensitization or desensitization) has long been a controversial treatment for asthma. Although beneficial effects upon clinically relevant outcomes have been demonstrated in randomized controlled trials, there remains a risk of severe and sometimes fatal anaphylaxis. The recommendations of professional bodies have ranged from cautious acceptance (1) to outright dismissal (2). A recent WHO position paper, which has been endorsed by eight other intemational and national bodies, concluded that allergen immunotherapy was an effective treatment for patients with allergic asthma (3). We have previously conducted a meta-analysis of 20 randomized controlled trials of allergen immunotherapy for asthma published between 1954 and 1990 (4). We subsequently conducted a systematic review for the Cochrane Collaboration, including a further 34 trials published between 1957 and 1997 (5). Both reviews concluded that subjects randomized to immunotherapy reported significantly fewer asthma symptoms, required significantly less asthma medication, and demonstrated both reduced nonspecific and reduced allergen-specific bronchial hyperreactivity (BHR) compared to those randomized to placebo. During recent years, there has been increasing interest in new allergen vaccines and new methods of delivery including oral, sublingual, and inhaled immunotherapy. Recombinant peptides containing the relevant epitopes, but lacking the ability to cross-link IgE bound to mast cells, have been evaluated in clinical trials. Finally, the Cochrane Collaboration has standardized protocols for systematic reviews and improved the statistical software for performing meta-analysis. Thus, it was again opportune to update our systematic review of allergen-specific immunotherapy for asthma.

[1]  L. Jäger The future of immunotherapy , 1999, Allergy.

[2]  M. Adachi,et al.  Effect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthma. , 1998, The Journal of allergy and clinical immunology.

[3]  M. Adachi,et al.  Long-term analysis of allergen-specific T cell clones from patients with asthma treated with allergen rush immunotherapy. , 1998, Cellular immunology.

[4]  A D Oxman,et al.  The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials , 1998, BMJ.

[5]  H. Matsuo,et al.  Effect of Immunotherapy on the Production of Eosinophil Adhesion-Inducing Activity from Mononuclear Cells in House-Dust-Mite-Sensitive Bronchial Asthma , 1998, International Archives of Allergy and Immunology.

[6]  Stevens,et al.  Comparison between the in vitro cytokine production of mononuclear cells of young asthmatics with and without immunotherapy (IT) , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  P. Papageorgiou,et al.  Double‐blind, placebo‐controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization , 1998, Allergy.

[8]  Giorgio Walter Canonica,et al.  Allergen immunotherapy: therapeutic vaccines for allergic diseases , 1998 .

[9]  J. Bousquet,et al.  Immunotherapy vs inhaled budesonide in bronchial asthma: an open, parallel comparative trial , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  K. Takagi,et al.  Computed tomographic findings in non‐specific interstitial pneumonia/fibrosis , 1998, Respirology.

[11]  J. Bousquet,et al.  Clinical efficacy of sublingual‐swallow immunotherapy: a double‐blind, olacebo‐controlled trial of a standardized five‐grass‐pollen extract in rhinitis , 1998, Allergy.

[12]  B. Chiang,et al.  Immunologic changes during immunotherapy in asthmatic children: increased IL-13 and allergen-specific IgG4 antibody levels. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  L. Elfman,et al.  Allergen‐Specific increase in interleukin (IL)‐4 and IL‐5 secretion from peripheral blood mononuclear cells during birch‐pollen immunotherapy , 1998, Allergy.

[14]  O. Kalayci,et al.  The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma. , 1998, Journal of investigational allergology & clinical immunology.

[15]  G. Canonica,et al.  Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis , 1998, The Lancet.

[16]  U. Wahn,et al.  The combined influence of immunotherapy and mite allergen reduction on bronchial hyperresponsiveness in mite-sensitive asthmatic children , 1998, European Journal of Pediatrics.

[17]  S. Petrović,et al.  Early effects of rush immunotherapy with Dermatophagoides pteronyssinus in asthmatics. , 1997, Journal of investigational allergology & clinical immunology.

[18]  J. Ioannidis,et al.  Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.

[19]  S. Martín,et al.  Clinical efficacy and tolerance of two year Lolium perenne sublingual immunotherapy. , 1997, Allergologia et immunopathologia.

[20]  E. Valovirta Capacity of specific immunotherapy in prevention of allergic asthma in children: the Preventive Allergy Treatment Study (PAT). , 1997, Journal of investigational allergology & clinical immunology.

[21]  K. Larsen,et al.  A 1‐year, placebo‐controlled, double‐blind house‐dust‐mite immunotherapy study in asthmatic adults , 1997, Allergy.

[22]  A. Frew,et al.  Clinical efficacy of specific immunotherapy to cat dander: a double‐blind placebo‐controlled trial , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[23]  J. Bousquet,et al.  Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. , 1997, The Journal of allergy and clinical immunology.

[24]  W. Pichler,et al.  Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity , 1997, Allergy.

[25]  J. Tonascia,et al.  A controlled trial of immunotherapy for asthma in allergic children. , 1997, The New England journal of medicine.

[26]  F. Simons,et al.  Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects. , 1996, International immunology.

[27]  E. Iemoli,et al.  Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[28]  I. Olkin,et al.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.

[29]  A. Franzese,et al.  Effects of enzyme-potentiated desensitization in the treatment of pollinosis: a double-blind placebo-controlled trial. , 1996, Journal of investigational allergology & clinical immunology.

[30]  C. Martínez-Cócera,et al.  A double‐blind, placebo‐controlled study of immunotherapy with grass‐pollen extract Alutard SQ during a 3–year period with initial rush immunotherapy , 1996, Allergy.

[31]  A. Cantani,et al.  Enzyme-potentiated desensitization in children with asthma and mite allergy: a double-blind study. , 1996, Journal of investigational allergology & clinical immunology.

[32]  D. Bernstein,et al.  Evaluation of household dust mite exposure and levels of specific IgE and IgG antibodies in asthmatic patients enrolled in a trial of immunotherapy. , 1996, The Journal of allergy and clinical immunology.

[33]  L. Delgado,et al.  Effects of immunotherapy on symptoms, PEFR, spirometry, and airway responsiveness in patients with allergic asthma to house‐dust mites (D. pteronyssinus) on inhaled steroid therapy , 1996, Allergy.

[34]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[35]  G. Hedlin,et al.  Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy. , 1995, The Journal of allergy and clinical immunology.

[36]  R. Lockey Adverse reactions associated with skin testing and immunotherapy. , 1995, Allergy proceedings : the official journal of regional and state allergy societies.

[37]  T. Lobera,et al.  Immunotherapy with a standardized Dermatophagoides pteronyssinus glutaraldehyde-modified extract against an unmodified extract: a comparative study of efficacy, tolerance and in vivo and in vitro modification of parameters. , 1995, Journal of investigational allergology & clinical immunology.

[38]  G. Senna,et al.  Local nasal immunotherapy for birch allergic rhinitis with extract in powder form , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[39]  P. Ventas,et al.  Immunotherapy with the storage mite lepidoglyphus destructor. , 1995, Allergologia et immunopathologia.

[40]  V. Feliziani,et al.  Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. , 1995, Allergologia et immunopathologia.

[41]  R. Puy,et al.  Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. , 1995, American journal of respiratory and critical care medicine.

[42]  C. Franco,et al.  A double-blind, placebo controlled study of Alpare mite D. pteronyssinus immunotherapy in asthmatic patients. , 1995, Allergologia et immunopathologia.

[43]  M. Cazzola,et al.  Immunotherapy with Alpare® in patients with respiratory allergy to Parietaria pollen: a two year double‐blind placebo‐controlled study , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[44]  A. Valero,et al.  Clinical and immunological effects of immunotherapy with glutaraldehyde modified house dust mite extract. , 1994, Allergologia et immunopathologia.

[45]  A. Moreira,et al.  [Topical nasal immunotherapy with Dermatophagoides pteronyssinus extract]. , 1994, Allergologia et immunopathologia.

[46]  J. Cuesta-Herranz,et al.  Monoclonal antibody-standardized cat extract immunotherapy: risk-benefit effects from a double-blind placebo study. , 1994, The Journal of allergy and clinical immunology.

[47]  G. Passalacqua,et al.  A three‐year double‐blind placebo‐controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[48]  J. C. Trindade,et al.  Specific immunotherapy 3 years follow-up in asthmatic children. , 1993, Allergologia et immunopathologia.

[49]  Y. Yanagihara,et al.  Effect of rush immunotherapy in house-dust-mite (HDM)-sensitive adult bronchial asthma: changes in in vivo and in vitro responses to HDM. , 1993, Internal medicine.

[50]  A. Scheynius,et al.  The effect of immunotherapy on T‐cell subsets in peripheral blood and bronchoalveolar lavage fluid in pollen‐allergic patients , 1993, Allergy.

[51]  L. Férnandez de Corres,et al.  Seasonal versus perennial immunotherapy: evaluation after three years of treatment. , 1993, Journal of investigational allergology & clinical immunology.

[52]  J. Saint-Remy,et al.  Significant reduction of nonspecific bronchial reactivity in patients with Dermatophagoides pteronyssinus-sensitive allergic asthma under therapy with allergen-antibody complexes. , 1993, The American review of respiratory disease.

[53]  M. Nagata,et al.  [The analysis of factors contributing to the safety and efficacy of rush immunotherapy in bronchial asthma]. , 1993, Arerugi = [Allergy].

[54]  S. Rak Effects of immunotherapy on the inflammation in pollen asthma , 1993, Allergy.

[55]  R. Dahl,et al.  A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects. , 1993, The Journal of allergy and clinical immunology.

[56]  J. Bousquet,et al.  Modulation of eicosanoid and histamine release from human dispersed lung cells by terfenadine , 1993, Allergy.

[57]  G. Salcedo,et al.  Evaluation of immune complexes after immunotherapy with wheat flour in bakers' asthma. , 1992, Annals of allergy.

[58]  R. Dahl,et al.  Immunotherapy in patients allergic to cat and dog dander , 1992, Allergy.

[59]  H. Van Bever,et al.  Effect of hyposensitization upon the immediate and late asthmatic reaction and upon histamine reactivity in patients allergic to house dust mite (Dermatophagoides pteronyssinus). , 1992, The European respiratory journal.

[60]  L. Corbetta,et al.  Improvement of fog and exercise-induced bronchoconstriction after local and subcutaneous immunotherapy in mite asthma. , 1992, Allergologia et immunopathologia.

[61]  M. Mancino,et al.  Immunotherapy by inhalation of allergen in powder in house dust allergic asthma--a double-blind study. , 1992, Journal of investigational allergology & clinical immunology.

[62]  W. Metzger,et al.  IMMUNOTHERAPY WITH POLLENS AND FUNGI , 1992, Immunology and Allergy Clinics of North America.

[63]  G. Moscato,et al.  Local immunotherapy by inhalation of a powder extract in asthma due to house dust mite Dermatophagoides pteronyssinus: a double-blind comparison with parenteral immunotherapy. , 1991, Journal of investigational allergology & clinical immunology.

[64]  J. Saint-Remy,et al.  Allergen‐antibody complexes can efficiently prevent seasonal rhinitis and asthma in grass pollen, hypersensitive patients , 1991, Allergy.

[65]  J. Bousquet,et al.  Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. , 1991, The Journal of allergy and clinical immunology.

[66]  G. Hedlin,et al.  Immunotherapy with cat- and dog-dander extracts , 1991 .

[67]  V. Brusasco,et al.  Local immunotherapy with Dermatophagoides extract in asthma. , 1991, The Journal of allergy and clinical immunology.

[68]  A. Sabbah,et al.  [Specific immunotherapy using Alpha-Fraction-Retard-D. pteronyssinus. Double-blind study in asthma]. , 1991, Allergie et immunologie.

[69]  P. Venge,et al.  Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. , 1990, The Journal of allergy and clinical immunology.

[70]  M. Jacquemin,et al.  Complexes of grass pollen allergens and specific antibodies reduce allergic symptoms and inhibit the seasonal increase of IgE antibody , 1990, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[71]  M. Mancino,et al.  Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. , 1990, Allergologia et immunopathologia.

[72]  K. Shimanuki,et al.  [Long-term follow up studies of bronchial asthma in children. II. Prognosis and complications, treatment and allergic evaluations]. , 1990, Arerugi = [Allergy].

[73]  H. Van Bever,et al.  Evolution of the late asthmatic reaction during immunotherapy and after stopping immunotherapy. , 1990, The Journal of allergy and clinical immunology.

[74]  J. Bousquet,et al.  Comparison between RAST and Pharmacia CAP system: a new automated specific IgE assay. , 1990, The Journal of allergy and clinical immunology.

[75]  P. Sly,et al.  Childhood asthma: Application of the international view of management in Australia and New Zealand * , 1990 .

[76]  S. Lebecque,et al.  Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes. , 1990, The Journal of clinical investigation.

[77]  H. Mosbech Who will benefit from hyposensitization? , 1990, Allergy.

[78]  Malling Hj Diagnosis and immunotherapy of mould allergy. With special reference to Cladosporium herbarum. , 1990 .

[79]  J. Bousquet,et al.  Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. , 1990, The Journal of allergy and clinical immunology.

[80]  J. Bousquet,et al.  Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. , 1990, The Journal of allergy and clinical immunology.

[81]  A. SánchezPalacios,et al.  Comparative clinical-immunological study of oral and subcutaneous immunotherapy in children with extrinsic bronchial asthma. , 1989 .

[82]  J. Bousquet,et al.  Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma. , 1989, The Journal of allergy and clinical immunology.

[83]  H. Mosbech,et al.  Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extract , 1989, Allergy.

[84]  X. Baur [Hyposensitization in bronchial asthma--still a current therapeutic procedure?]. , 1989, Medizinische Klinik.

[85]  H. Mosbech,et al.  Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extract , 1989, Allergy.

[86]  A. Blanco‐quirós,et al.  Rush immunotherapy with a standardized Bermuda grass pollen extract. , 1989, Annals of allergy.

[87]  T. Kristensen,et al.  Immunotherapy with dog and cat extracts in children , 1989, Allergy.

[88]  W. Stevens,et al.  Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) , 1989, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[89]  P. Kuna,et al.  The effect of preseasonal immunotherapy on the production of histamine-releasing factor (HRF) by mononuclear cells from patients with seasonal asthma: results of a double-blind, placebo-controlled, randomized study. , 1989, The Journal of allergy and clinical immunology.

[90]  J. Hałuszka,et al.  [Results of immunotherapy with HDM (Bencard) in children with bronchial asthma]. , 1989, Pediatria polska.

[91]  E. Pastorello,et al.  A double‐blind study of hyposensitization with an alginate conjugated extract of D. pteronyssinus (Conjuvac®) in patients with perennial rhinitis , 1989 .

[92]  A. Kagey‐Sobotka,et al.  Immunotherapy for cat asthma. , 1988, The Journal of allergy and clinical immunology.

[93]  J. Bousquet,et al.  Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. , 1988, The Journal of allergy and clinical immunology.

[94]  P. Venge,et al.  The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. , 1988, The Journal of allergy and clinical immunology.

[95]  U. Wahn,et al.  Prospective study on immunologic changes induced by two different Dermatophagoides pteronyssinus extracts prepared from whole mite culture and mite bodies. , 1988, The Journal of allergy and clinical immunology.

[96]  H. Chai,et al.  Cat- or dog-induced immediate and late asthmatic responses before and after immunotherapy. , 1988, The Journal of allergy and clinical immunology.

[97]  J. Bousquet,et al.  Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. , 1988, The Journal of allergy and clinical immunology.

[98]  W. Stevens,et al.  Modification of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) or grass pollen , 1988, Allergy.

[99]  H. Ipsen,et al.  Immunotherapy with partially purified and standardized tree pollen extracts , 1988, Allergy.

[100]  B. Björkstén,et al.  Oral immunotherapy in birch pollen hay fever. , 1987, The Journal of allergy and clinical immunology.

[101]  R. Moss,et al.  Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy. , 1986, The Journal of allergy and clinical immunology.

[102]  E. Valovirta,et al.  Immunotherapy in allergy to dog. Immunologic and clinical findings of a double-blind study. , 1986, Annals of allergy.

[103]  S. Dreborg,et al.  Diagnosis and Immunotherapy of Mould Allergy , 1986, Allergy.

[104]  B. Björkstén,et al.  Oral Immunotherapy of Children with Rhinoconjunctivitis due to Birch Pollen Allergy A Double Blind Study , 1986, Allergy.

[105]  G. Hedlin,et al.  Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma. , 1986, The Journal of allergy and clinical immunology.

[106]  C. Collins-Williams Non-allergic bronchial hyperreactivity in asthmatic children decreases with age and increases with mite immunotherapy. , 1986, Annals of allergy.

[107]  A. Koivikko,et al.  A Double‐Blind, Multicenter Immunotherapy Trial in Children, Using a Purified and Standardized Cladosporium herbarum Preparation I. Clinical Results , 1986, Allergy.

[108]  Rocha Em Effect of 2 therapeutic protocols in minor forms of respiratory allergy , 1986 .

[109]  J. Bousquet,et al.  Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment. , 1985, The Journal of allergy and clinical immunology.

[110]  R. Djurup,et al.  Oral Administration of Grass Pollen to Hay Fever Patients , 1985, Allergy.

[111]  Moshkevich Vs Local immunotherapy for chronic respiratory allergic pathology with allergen aerosols. II. Treatment of bronchial asthma. , 1985 .

[112]  A. Murray,et al.  Non-allergic bronchial hyperreactivity in asthmatic children decreases with age and increases with mite immunotherapy. , 1985, Annals of allergy.

[113]  J. Bousquet,et al.  Comparison between rush immunotherapy with a standardized allergen and an alum adjuved pyridine extracted material in grass pollen allergy , 1985, Clinical allergy.

[114]  J. Darbyshire,et al.  A controlled trial of oral hyposensitization in pollen asthma and rhinitis in children , 1984, Clinical allergy.

[115]  G. Pauli,et al.  Clinical and immunologic evaluation of tyrosine-adsorbed Dermatophagoides pteronyssinus extract: a double-blind placebo-controlled trial. , 1984, The Journal of allergy and clinical immunology.

[116]  S. Findlay,et al.  Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses. , 1984, The Journal of allergy and clinical immunology.

[117]  E. Valovirta,et al.  Immunotherapy in allergy to dog: a double-blind clinical study. , 1984, Annals of allergy.

[118]  E. Hey,et al.  A controlled trial of hyposensitization with adsorbed tyrosine Dermatophagoides pteronyssinus antigen in childhood asthma: in vivo aspects , 1984, Clinical allergy.

[119]  E. Hey,et al.  In vitro investigations in asthmatic children undergoing hyposensitization with tyrosine‐adsorbed Dermatophagoides pteronyssinus antigen , 1984, Clinical allergy.

[120]  T. Haahtela,et al.  Hyposensitization in hay fever with grass pollen extracts: a three-year study comparing a dialysed alum adsorbed extract with allpyral. , 1984, Annals of allergy.

[121]  E. Pastorello,et al.  Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis. , 1984, The Journal of allergy and clinical immunology.

[122]  R. Patterson,et al.  A double-blind histamine placebo-controlled trial of polymerized whole grass for immunotherapy of grass allergy. , 1983, The Journal of allergy and clinical immunology.

[123]  B. Weeke,et al.  Orally Administered Grass Pollen , 1983, Allergy.

[124]  J. Kalbfleisch,et al.  Comparison of Rinkel injection therapy with standard immunotherapy. , 1982, The Journal of allergy and clinical immunology.

[125]  O. Østerballe Immunotherapy with Grass Pollen Major Allergens , 1982 .

[126]  R. Patterson,et al.  A double-blind, placebo-controlled trial of polymerized whole ragweed for immunotherapy of ragweed allergy. , 1982, The Journal of allergy and clinical immunology.

[127]  M. Turner,et al.  Failure of hyposensitisation in treatment of children with grass-pollen asthma , 1982, British medical journal.

[128]  R. Urbanek,et al.  [Efficacy of oral hyposensitization treatment in house dust mite allergy (author's transl)]. , 1982, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde.

[129]  H. Chai,et al.  Efficacy of rush immunotherapy in decreasing bronchial sensitivity to inhaled antigens in perennial childhood asthma. , 1981, Annals of allergy.

[130]  Wu Th,et al.  Treatment of asthmatic patients sensitive to mites (Dermatophagoides farinae); a four-year study of immunotherapy with an extract of Dermatophagoides farinae. , 1981 .

[131]  G. Pauli,et al.  Grass Pollen Hyposensitization versus Placebo Therapy , 1981, Allergy.

[132]  M. Reinert,et al.  [Hyposensitization with tyrosine-allergoids (author's transl)]. , 1981, Praxis und Klinik der Pneumologie.

[133]  P. Choovoravech Effect of immunotherapy: treatment with mite and other aeroallergens in Thai allergic patients. , 1980, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[134]  U. Wahn,et al.  Efficacy and specificity of immunotherapy with laboratory animal allergen extracts. , 1980, The Journal of allergy and clinical immunology.

[135]  B. Wüthrich,et al.  [Pollinosis. II. Specific hyposensitization: indications and results of treatment. A study with the allergen preparation Stallergenes-Depot in the pollen season of 1976, 1977 and 1978]. , 1980, Schweizerische medizinische Wochenschrift.

[136]  A. MartorellAragonés,et al.  [Bronchial asthma. Clinical evolution with hyposensitization (author's transl)]. , 1980 .

[137]  A. Sychłowy,et al.  [Treatment of asthma caused by house-dust mites with a combination of intal and vaccine adsorbed on tyrosine]. , 1979, Pediatria polska.

[138]  S. Ahlstedt,et al.  Immunotherapy in Spring‐Time Hay Fever , 1979, Allergy.

[139]  A. Szczeklik,et al.  [Multicenter controlled trial of desensitization treatment of pollen-induced hay fever and asthma with pollinex vaccine]. , 1979, Polski tygodnik lekarski.

[140]  M. Götz,et al.  [Immunotherapy of allergic disease. Studies on 460 patients]. , 1979, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[141]  A. Swatko,et al.  [Evaluation of the effectiveness of desensitization in bronchial asthma caused by house dust mites or grass pollen in the light of clinical results and the histamine and polymyxin inhalation test]. , 1979, Polski tygodnik lekarski.

[142]  Kozhem'iaka Ai,et al.  Effectiveness of the specific hyposensitization of children with allergoses using a peroral vaccine from house dust , 1979 .

[143]  E. Hey,et al.  CONTROLLED TRIAL OF HYPOSENSITISATION TO DERMATOPHAGOIDES PTERONYSSINUS IN CHILDREN WITH ASTHMA , 1978, The Lancet.

[144]  L. Lichtenstein,et al.  The clinical and immunologic specificity of immunotherapy. , 1978, The Journal of allergy and clinical immunology.

[145]  R. Avila,et al.  Results of a clinical trial with a Dermatophagoides pteronyssinus tyrosine adsorbed vaccine. , 1978, Allergologia et immunopathologia.

[146]  F. C. Lowell,et al.  Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of bronchial responses to cat allergen and histamine. , 1978, The Journal of allergy and clinical immunology.

[147]  L. Lichtenstein,et al.  The role of ragweed pollen in autumnal asthma. , 1977, The Journal of allergy and clinical immunology.

[148]  J. Warner,et al.  Hyposensitisation with house dust mite vaccine in bronchial asthma. , 1976, British medical journal.

[149]  H. Pence,et al.  Immunotherapy for mountain cedar pollinosis. A double-blind controlled study. , 1976, The Journal of allergy and clinical immunology.

[150]  D. Munro-Ashman,et al.  Treatment of allergy to house dust with pyridine-extracted alum-precipitated extracts of the house dust mite. , 1976, Annals of allergy.

[151]  P. Choovoravech Effect of immunotherapy in bronchial asthma: treatment with extracts of house dust and mite. , 1974, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[152]  A. P. Norman,et al.  A double blind controlled trial of house mite fortified house dust vaccine in childhood asthma , 1974, Clinical allergy.

[153]  V. Aa,et al.  Letter: Nutritional muscular dystrophy and human myocardial infarction. , 1973 .

[154]  M. Megson,et al.  Hyposensitization with Dermatophagoides pteronyssinus in house dust allergy: a controlled study of clinical and immunological effects , 1973, Clinical allergy.

[155]  B. Wüthrich,et al.  [Peroral desensitization of inhalation allergies in childhood: treatment results]. , 1973, Schweizerische medizinische Wochenschrift.

[156]  M. Tuchinda,et al.  Effect of immunotherapy in chronic asthmatic children. , 1973, The Journal of allergy and clinical immunology.

[157]  J. Meade,et al.  Correlation of type specific fluorescent antibodies to ragweed with symptomatology: double-blind study. , 1972, Annals of allergy.

[158]  L. Lichtenstein,et al.  A single year of immunotherapy for ragweed hay fever. Immunologic and clinical studies. , 1971, Annals of internal medicine.

[159]  A. Smith,et al.  Hyposensitization with Dermatophagoides pteronyssinus Antigen: Trial in Asthma Induced by House Dust , 1971, British medical journal.

[160]  B. Wüthrich,et al.  [Specific therapy of pollinosis. Results of desensitization with two different semi-depot allergen extracts (Allpyral and Suspal)]. , 1971, Schweizerische medizinische Wochenschrift.

[161]  K. Maunsell,et al.  Hyposensitisation in mite asthma. , 1971, Lancet.

[162]  K. Aas HYPOSENSITIZATION IN HOUSE DUST ALLERGY ASTHMA , 1971, Acta paediatrica Scandinavica.

[163]  B. Lewis Points from Letters: Race and Commonwealth , 1970 .

[164]  Vooren Ph Double blind desensitization in asthma , 1969 .

[165]  Taub Sj Ragweed hayfever and asthma. , 1969 .

[166]  E. Mellits,et al.  Immunotherapy of pollinosis in children: investigation of the immunologic basis of clinical improvement. , 1969, The New England journal of medicine.

[167]  D. Johnstone,et al.  The value of hyposensitization therapy for bronchial asthma in children--a 14-year study. , 1968, Pediatrics.

[168]  P. Heaf,et al.  Depot grass-pollen injections in asthma: effect of repeated treatment on clinical response and measured bronchial sensitivity. , 1967, British medical journal.

[169]  S. Sanders The treatment of seasonal hay fever and asthma in children. A controlled trial of pre-seasonal depot pollen therapy. , 1966, The Practitioner.

[170]  W. Tattersall,et al.  BRITISH Tuberculosis Association. , 1965, Tubercle.

[171]  R. Weston,et al.  SELF-TEACHING IN HOSPITAL. , 1965, Lancet.

[172]  G. J. Cunningham,et al.  VENTILATION OF OPERATING-THEATRES. , 1964, Lancet.

[173]  D. Johnstone,et al.  Value of hyposensitization therapy for perennial bronchial asthma in children. , 1961, Pediatrics.

[174]  S. J. Levin Hyposensitizing (Immunizing) Inoculations in Hay Fever and Asthma , 1959 .

[175]  D. E. Johnstone Study of the role of antigen dosage in the treatment of pollenosis and pollen asthma. , 1957, A.M.A. journal of diseases of children.

[176]  S. Kraepelien,et al.  Specific Desensitization in Bronchial Asthma in Childhood , 1957, Acta paediatrica.

[177]  D. Gairdner The Integration of Medicine , 1955 .

[178]  O. Swineford,et al.  Treatment of pollen hay fever and asthma with aerosols of pollen extracts. , 1955, The Journal of allergy.

[179]  A. Frankland,et al.  Prophylaxis of summer hay-fever and asthma: a controlled trial comparing crude grass-pollen extracts with the isolated main protein component. , 1954, Lancet.

[180]  A. Unger,et al.  Treatment of bronchial asthma. , 1952, Journal of the American Medical Association.

[181]  E. Bruun CONTROL EXAMINATION OF THE SPECIFICITY OF SPECIFIC DESENSITIZATION IN ASTHMA , 1949, Acta allergologica.

[182]  Hisashi Matsubara,et al.  Study of specific IgE and IgG4 antibodies to mite antigen in asthmatic children during immunotherapy , 1998 .

[183]  M. Abramson,et al.  Ragweed immunotherapy in adult asthma. , 1996, The New England journal of medicine.

[184]  E. Valovirta,et al.  198 Immunotherapy as preventive allergy treatment (PAT) , 1996 .

[185]  H. Nelson,et al.  Safety and efficacy of oral immunotherapy with standardized cat extract. , 1994, The Journal of allergy and clinical immunology.

[186]  R. Ariano,et al.  Local Immunotherapy of Seasonal Allergic Rhinitis in Children Due to Parietaria officinalis Pollen: A Preliminary Report , 1993 .

[187]  S. Mills The development of the complementary medical professions , 1993 .

[188]  P. Sánchez Guijo,et al.  Monitoring of various types of immunotherapy with gramineal pollens. I. Variation of clinical and biochemical parameters. , 1992, Allergologia et immunopathologia.

[189]  H. Malling Diagnosis and immunotherapy of mould allergy. With special reference to Cladosporium herbarum. , 1990, Danish medical bulletin.

[190]  X. Leng,et al.  A double-blind trial of oral immunotherapy for Artemisia pollen asthma with evaluation of bronchial response to the pollen allergen and serum-specific IgE antibody. , 1990, Annals of allergy.

[191]  G. Hedlin,et al.  Immunotherapy with cat- and dog-dander extracts. IV. Effects of 2 years of treatment. , 1989, The Journal of allergy and clinical immunology.

[192]  A. Sánchez Palacios,et al.  Comparative clinical-immunological study of oral and subcutaneous immunotherapy in children with extrinsic bronchial asthma. , 1989, Allergologia et immunopathologia.

[193]  B. Kang,et al.  The role of immunotherapy in cockroach asthma. , 1988, The Journal of asthma : official journal of the Association for the Care of Asthma.

[194]  E. M. Rocha [Effect of 2 therapeutic protocols in minor forms of respiratory allergy]. , 1986, Allergie et immunologie.

[195]  V. S. Moshkevich Local immunotherapy for chronic respiratory allergic pathology with allergen aerosols. II. Treatment of bronchial asthma. , 1985, Allergologia et immunopathologia.

[196]  H. Richerson,et al.  121 Modification of late asthmatic responses (LAR) during immunotherapy for Alternaria -induced asthma , 1983 .

[197]  T. Wun,et al.  Treatment of asthmatic patients sensitive to mites (Dermatophagoides farinae); a four-year study of immunotherapy with an extract of Dermatophagoides farinae. , 1981, Annals of allergy.

[198]  F. Muñoz-López Immunotherapy--methods of treatment and results in children. , 1981, Allergologia et immunopathologia.

[199]  D. J. Buchanan,et al.  A double blind controlled trial of Bencard house dust mite (Migen) hyposensitisation in Zambian asthmatics. , 1980, Medical journal of Zambia.

[200]  A. I. Kozhem'iaka,et al.  [Effectiveness of the specific hyposensitization of children with allergoses using a peroral vaccine from house dust]. , 1979, Pediatriia akusherstvo i ginekologiia.

[201]  D. Newton,et al.  House dust mite hyposensitization. , 1978, British journal of diseases of the chest.

[202]  P. Choovoravech,et al.  Effect of immunotherapy in bronchial asthma: treatment with mite extract absorbed on tyrosine. , 1976, Current medical research and opinion.

[203]  P. Vooren [Double blind desensitization in asthma]. , 1969, Nederlands tijdschrift voor geneeskunde.